Treatment of Sleep Apnea With Oral Appliances

• ClinicalTrials.gov Identifier: NCT01209468
• Recruitment Status: Unknown
• First Posted: September 27, 2010
• Last Update Posted: September 27, 2010
• Sponsor: The University of Hong Kong
• Information provided by: The University of Hong Kong

Study Description

Brief Summary:

Obstructive sleep apnoea (OSA) is a serious and common disorder affecting one in twenty-five men and one in fifty women over the age of 30. This breathing abnormality occurs during sleep and is characterised by snoring and episodes of sleep disturbances. The symptoms of untreated OSA (e.g. excessive daytime sleepiness), can result in significant reductions in the patients' quality of life. The key treatment modalities today include Continuous Positive Air Pressure (CPAP), surgery and the use of oral appliances (OAs). Increasingly, OAs have been advocated in the treatment of the symptoms of OSA since they offer a non-invasive form of treatment and also because patients often prefer this treatment to other treatment modalities. There is increasing evidence to support the effectiveness of OAs in the management of OSA, at least as a short term measure. What is still unclear is which types of OA are most effective and whether OAs are effective in the long term management of OSA. This randomized clinical trial aims to evaluate two differently designed OAs in terms of their effect on patients' quality of life and on the physiological symptoms of OSA (apnoea/hypopnoea index AHI). Around 45 patients with OSA will be recruited from a pool of patients referred to the dental hospital for treatment from the medical faculty. The treatment with OAs will commence after randomization to two treatment groups; follow-up examinations will take place over a period of 12 months. The results of this study will help inform practitioners and patients of the feasibility of using OAs in the long term management of OSA and help determine the most appropriate type of OAs for the management of OSA and improvement in quality of life.

Condition or disease	Intervention/treatment	Phase
Obstructive Sleep Apnea	Device: monobloc oral appliance; Device: twinblock oral appliance	Not Applicable

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 45 participants
• Allocation: Randomized
• Intervention Model: Crossover Assignment
• Masking: Triple (Participant, Investigator, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: A Randomized Clinical Trial of the Treatment of Obstructive Sleep Apnoea Using Oral Appliances
• Study Start Date: June 2008
• Estimated Primary Completion Date: November 2010
• Estimated Study Completion Date: December 2010

Arms and Interventions

Arm	Intervention/treatment
Active Comparator: oral appliance 2; Patients in treatment arm/group B will have a customized twinblock OA constructed for them individually. They will undergo an appliance acclimatization period of 4-5 weeks. Three months after baseline assessments - T1 (6 weeks of 'active' treatment), physiological measurements will be evaluated, clinical oral examinations conducted, quality of life and compliance assessed. Following this, a customized monobloc OA will be constructed for subjects individually and they will acclimatize to it for 4-5 weeks (so that the mandible is protruded to the maximum position they feel comfortable with when the appliance is worn). Prior to the active treatment phase, patients will not wear the monobloc OA for 1 week (washout phase). Three months later - T2 (6 weeks of 'active' treatment), all the previous measurements will be conducted again.	Device: twinblock oral appliance; two-piece oral appliance
Experimental: oral appliance 1; Patients in treatment arm/group A will have a customized monobloc OA constructed for them individually. They will undergo an appliance acclimatization period of 4-5 weeks. Three months after baseline assessments - T1 (6 weeks of 'active' treatment), physiological measurements will be evaluated, clinical oral examinations conducted, quality of life and compliance assessed. Following this, a customized twin-bloc OA will be constructed for subjects individually and they will acclimatize to it for 4-5 weeks (so that the mandible is protruded to the maximum position they feel comfortable with when the appliance is worn). Prior to the active treatment phase, patients will not wear the twin-bloc OA for 1 week (washout phase). Three months later - T2 (6 weeks of 'active' treatment), all the previous measurements will be conducted again.	Device: monobloc oral appliance; one piece oral appliance

Outcome Measures

Primary Outcome Measures :

1. Quality of life [ Time Frame: 6 months ]

   Quality of life scores collected by the Sleep Apnoea Quality of Life Index questionnaire.

   The minimum important clinical difference (MICD) for this index is a change in score of 1. A mean change of at least 1 in the SAQLI scores (SD=1.1) between the two groups (treated two types of oral appliances) is expected.

Secondary Outcome Measures :

1. objective OSA markers [ Time Frame: 6 months ]

   Physiological variables measured during polysomnography, such as apnea-hypopnea index (AHI).

   Complete response: Resolution of symptoms and improvement of objective variables Partial response: more than 50% reduction in AHI but AHI's remaining above 5/h Failure: ongoing clinincal symptoms and/or less than 50% reduction in AHI

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

• Aged 18 or older
• AHI ≥ 10-30/h, and those who do not tolerate CPAP or refused CPAP if AHI >30
• A score of > 10 on the Epworth Sleepiness Scale
• Body Mass Index <35kg/m
• Those who are competent to give written informed consent
• have adequate dental anchoring structures (<10 periodontally healthy teeth per arch)

Exclusion Criteria:

• Previous surgery to upper respiratory airway
• Concurrent unstable cardiovascular disease, neurological, mental or psychiatric disorders
• Recent major surgery in the last 6 months
• Pregnancy
• Epilepsy
• temporomandibular joint (TMJ) disfunction (pain during mandibular advancement or limitation of mouth opening)
• untreated dental decay

Contacts and Locations

Contacts

Contact: Colman McGrath, Professor; +852 28590513; mcgrathc@hkucc.hku.hk

Contact: Anika Ahrens, MA; anikaahrens@yahoo.com

Locations

Hong Kong

Prince Philip Dental Hospital; Recruiting

Hong Kong, Hong Kong

Principal Investigator: Colman McGrath, Professor

Sponsors and Collaborators

The University of Hong Kong

Investigators

• Principal Investigator: Colman McGrath, Professor; Faculty of Dentistry, HKU

More Information

• Responsible Party: Professor Colman McGrath, Faculty of Dentistry, HKU
• ClinicalTrials.gov Identifier: NCT01209468
• Other Study ID Numbers: 1
• First Posted: September 27, 2010
• Last Update Posted: September 27, 2010
• Last Verified: September 2010

Additional relevant MeSH terms:

Apnea; Sleep Apnea Syndromes; Sleep Apnea, Obstructive; Respiration Disorders; Respiratory Tract Diseases; Signs and Symptoms, Respiratory; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases